Home LiteratureArticle Details
PMID: 1548779 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Human immunodeficiency virus type 1 entry into T cells: more-rapid escape from an anti-V3 loop than from an antireceptor antibody.

Journal of virology ·Vol. 66 ·No. 4 ·1992-04-00 ·Pages 2547-50

Lu S, Putney SD, Robinson HL

Abstract

The entry of human immunodeficiency virus type 1 into two T-cell lines has been analyzed to determine the relative time courses with which virus entry can be blocked (i) by washing, (ii) by adding a monoclonal antibody to the V3 loop of gp120 that neutralizes without blocking CD4 binding (0.5 beta), or (iii) by adding an antireceptor monoclonal antibody that competes for virus binding (leu3a). During entry into C8166 cells, 50% escape from the wash as well as the anti-V3 loop antibody required 20 min, whereas 50% escape from the leu3a block required 45 minutes. In contrast, during entry into H9 cells, 50% escape from the wash block required 50 min, 50% escape from the anti-V3 loop antibody required 110 min, and 50% escape from the antireceptor antibody required 190 min. These results demonstrate that the times required for entering virus to escape each of the blocks were cell type specific. They also demonstrate that V3 loop-dependent steps occur relatively early in entry and suggest that binding of gp120 to CD4 is important for late as well as early steps in human immunodeficiency virus type 1 entry.

MeSH Terms
Antibodies, Monoclonal/immunology Cell Line HIV Antibodies/immunology HIV Envelope Protein gp120/metabolism HIV-1/immunology,physiology Humans Kinetics Neutralization Tests Peptide Fragments/metabolism Receptors, HIV/immunology,metabolism T-Lymphocytes/microbiology Virus Replication
Chemicals
Antibodies, Monoclonal HIV Antibodies HIV Envelope Protein gp120 HIV envelope protein gp120 (305-321) Peptide Fragments Receptors, HIV
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Lu S
Department of Pathology, University of Massachusetts Medical Center, Worcester 01655.
Putney S D
Robinson H L
References (25)
25 references, click to expand
  1. Human immunodeficiency virus type 1 NL4-3 replication in four T-cell lines: rate and efficiency of entry, a major determinant of permissiveness.
    J Virol. 1991 Jul;65(7):3900-2 PMID: 1674969
  2. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.
    Science. 1987 Sep 11;237(4820):1351-5 PMID: 3629244
  3. Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.
    J Virol. 1991 Mar;65(3):1133-40 PMID: 1995942
  4. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?
    AIDS Res Hum Retroviruses. 1991 Jan;7(1):3-16 PMID: 2015114
  5. Crystal structure of an HIV-binding recombinant fragment of human CD4.
    Nature. 1990 Nov 29;348(6300):419-26 PMID: 2247146
  6. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.
    Science. 1990 Aug 24;249(4971):932-5 PMID: 2392685
  7. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope.
    J Virol. 1988 Jun;62(6):2107-14 PMID: 2452899
  8. Patch clamp studies of single cell-fusion events mediated by a viral fusion protein.
    Nature. 1989 Nov 30;342(6249):555-8 PMID: 2586627
  9. Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4.
    J Virol. 1988 Nov;62(11):4195-200 PMID: 2845130
  10. Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis.
    J Cell Biol. 1988 Sep;107(3):959-68 PMID: 3262112
  11. Tryptase TL2 in the membrane of human T4+ lymphocytes is a novel binding protein of the V3 domain of HIV-1 envelope glycoprotein gp 120.
    FEBS Lett. 1991 Jul 29;286(1-2):233-6 PMID: 1677898
  12. Structural and functional features of the HIV envelope glycoprotein and considerations for vaccine development.
    Biotechnology. 1990;14:81-110 PMID: 1691670
  13. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains.
    Nature. 1990 Nov 29;348(6300):411-8 PMID: 1701030
  14. A novel membrane-bound serine esterase in human T4+ lymphocytes immunologically reactive with antibody inhibiting syncytia induced by HIV-1. Purification and characterization.
    J Biol Chem. 1990 Dec 15;265(35):21979-85 PMID: 1979328
  15. Identification of membrane anchorage domains of the HIV-1 gp160 envelope glycoprotein precursor.
    J Acquir Immune Defic Syndr. 1991;4(1):34-40 PMID: 1984054
  16. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
    Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2189-93 PMID: 2006155
  17. AIDS pathogenesis: HIV envelope and its interaction with cell proteins.
    Immunol Today. 1990 Nov;11(11):418-25 PMID: 2078296
  18. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
    Proc Natl Acad Sci U S A. 1990 Jan;87(2):648-52 PMID: 2300552
  19. Enhancement of SIV infection with soluble receptor molecules.
    Science. 1990 Mar 2;247(4946):1084-8 PMID: 2309120
  20. HIV: early virus-cell interactions.
    J Acquir Immune Defic Syndr. 1990;3(10):965-74 PMID: 2398460
  21. Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection.
    FEBS Lett. 1989 May 8;248(1-2):48-52 PMID: 2470618
  22. The gp120-CD4 interface: structural, immunological and pathological considerations.
    Biochim Biophys Acta. 1989 Dec 27;989(3):281-300 PMID: 2559777
  23. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
    Proc Natl Acad Sci U S A. 1989 Sep;86(17):6768-72 PMID: 2771954
  24. Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism.
    EMBO J. 1988 Feb;7(2):513-8 PMID: 3259178
  25. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity.
    Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):70-4 PMID: 1729720
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1992-04-00
Pages
2547-50
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC289056
Subset
IM
Grants
NIAID NIH HHS · AI 24474 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]